88 related articles for article (PubMed ID: 373190)
21. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
22. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.
Halloran PF; Schlaut J; Solez K; Srinivasa NS
Transplantation; 1992 Mar; 53(3):550-5. PubMed ID: 1549846
[TBL] [Abstract][Full Text] [Related]
23. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
[TBL] [Abstract][Full Text] [Related]
24. Detection of antidonor antibody: advantages of fibroblast target cells.
Halloran PF; Aprile M; Haddad G; Robinette M
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():49-55. PubMed ID: 386320
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
26. Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation.
Lee KW; Kim SJ; Lee DS; Lee HH; Joh JW; Lee SK; Oh HY; Kim DJ; Kim YG; Huh WS; Oh WI; Lee BB
Transplant Proc; 2004 Sep; 36(7):2009-10. PubMed ID: 15518726
[TBL] [Abstract][Full Text] [Related]
27. Effect of HLA-DR matching between living kidney donors and recipients and of pretransplant blood transfusions on graft survival.
Akiyama N; Sugimoto H; Kusaba R; Takahashi I; Ohsawa N; Inou T; Samaru Y
Jpn J Exp Med; 1981 Feb; 51(1):37-43. PubMed ID: 6458714
[TBL] [Abstract][Full Text] [Related]
28. Induction of antibody-dependent cellular cytotoxicity against endothelial cells by renal transplantation.
Miltenburg AM; Meijer-Paape ME; Weening JJ; Daha MR; van Es LA; van der Woude FJ
Transplantation; 1989 Oct; 48(4):681-8. PubMed ID: 2799923
[TBL] [Abstract][Full Text] [Related]
29. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
[TBL] [Abstract][Full Text] [Related]
30. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.
Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
Exp Clin Transplant; 2009 Jun; 7(2):104-9. PubMed ID: 19715514
[TBL] [Abstract][Full Text] [Related]
31. Mixed lymphocyte culture responses. Lack of correlation with cadaveric renal allograft survival and blood transfusions.
Jeffery JR; Cheung K; Masniuk J; Taylor D
Transplantation; 1984 Jul; 38(1):42-5. PubMed ID: 6234685
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
Rose ML; Smith JD
Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
[TBL] [Abstract][Full Text] [Related]
33. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
34. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch.
Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT
Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127
[TBL] [Abstract][Full Text] [Related]
35. Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity.
van Meerten T; van Rijn RS; Hol S; Hagenbeek A; Ebeling SB
Clin Cancer Res; 2006 Jul; 12(13):4027-35. PubMed ID: 16818702
[TBL] [Abstract][Full Text] [Related]
36. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
Tripathy NK; Upadhyaya S; Sinha N; Nityanand S
J Rheumatol; 2001 Apr; 28(4):805-8. PubMed ID: 11327255
[TBL] [Abstract][Full Text] [Related]
37. Patterns of immunological anti-donor reactivity in renal allotransplanted patients--a prospective study.
Kristensen T; Grunnet N; Hansen HE; Fjeldborg O; Olsen S; Jørgensen F; Kissmeyer-Nielsen F
Scand J Urol Nephrol Suppl; 1977; (42):46-50. PubMed ID: 356221
[TBL] [Abstract][Full Text] [Related]
38. Endothelial antibodies in renal transplantation.
Paul LC; van Es LA; Claas FH; Kalff MW
Proc Eur Dial Transplant Assoc; 1979; 16():431-6. PubMed ID: 398516
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation.
Ishida H; Tanabe K; Furusawa M; Ishizuka T; Hayashi T; Tokumoto T; Miyamoto N; Shirakawa H; Shimmura H; Shimizu T; Toma H
Transpl Int; 2005 Feb; 18(2):163-8. PubMed ID: 15691268
[TBL] [Abstract][Full Text] [Related]
40. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
Kinouchi T; Bander NH; Kotake T
J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
